In the context of NEC, a recent study from Mihi et al., demonstrated a protective role of IL-22 treatment in attenuating intestinal injury and enhancing epithelial proliferation in experimental NEC (108). The gene discussed is IL22; the disease is necrotizing enterocolitis.